Insider Transactions Reported by 38 Insiders of Xilio Therapeutics, Inc.

Symbol
XLO on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Xilio Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GILEAD SCIENCES, INC. 10%+ Owner $36,949,953 26 Nov 2025
Yekaterina Chudnovsky 10%+ Owner $5,320,000 07 Jun 2024
SV7 Impact Medicine Fund LP 10%+ Owner $2,678,630 26 Oct 2021
Bain Capital Life Sciences Investors, LLC 10%+ Owner $2,328,493 08 Dec 2021
James E. Flynn Possible Member of 10% Group, 10%+ Owner $1,898,994 26 Oct 2021
Atlas Venture Fund XI, L.P. 10%+ Owner $1,762,629 08 Feb 2024
FMR LLC Other* $1,583,366 26 Oct 2021
TAKEDA PHARMACEUTICAL CO LTD 10%+ Owner $1,224,350 26 Oct 2021
RiverVest Venture Fund IV, L.P. 10%+ Owner $1,196,399 26 Oct 2021
Rock Springs Capital Management LP 10%+ Owner $1,042,872 26 Oct 2021
BAY CITY CAPITAL LLC 10%+ Owner $937,477 26 Oct 2021
Merck KGaA 10%+ Owner $565,085 26 Oct 2021
Rene Russo PRESIDENT AND CEO, Director $372,363 +$24,680 +7.1% 31 Dec 2025
FIL Ltd Other* $181,525 26 Oct 2021
Alexandria Venture Investments, LLC 10%+ Owner $138,131 26 Oct 2021
SIMON TOMLINSON 10%+ Owner $108,827 21 Oct 2021
of Ulrich Rodeck Estate 10%+ Owner $83,066 21 Oct 2021
John Williams 10%+ Owner $83,066 21 Oct 2021
TIMOTHY P. CLACKSON 10%+ Owner $75,493 21 Oct 2021
Christopher James Frankenfield Chief Financial Officer $73,107 -$4,522 -5.8% 31 Dec 2025
Katarina Luptakova Chief Medical Officer $73,002 31 Dec 2025
James Samuel Shannon Director $48,202 +$48,085 +41098% 16 Jun 2025
Kevin Brennan Svp, Finance And Accounting $19,697 -$1,174 -5.6% 31 Dec 2025
RACHEL HUMPHREY Director $7,839 21 Oct 2021
Salvatore Giovine Chief Financial Officer 22 Feb 2022
Christina Rossi Director 11 Jun 2025
Daniel J. Curran Director 11 Jun 2025
Sara Bonstein Director 11 Jun 2025
Aoife Brennan Director 11 Jun 2025
Akintunde Olatokumbo Bello Director 10 Jun 2025
Tomas J. Heyman Director 12 Jun 2023
ROBERT W. ROSS Director 11 Jun 2025
DANIEL LYNCH Director, 10%+ Owner 21 Oct 2021
Yuan Xu Director 11 Jun 2025
Martin H. Huber Jr. President And Head Of R&D 16 Aug 2023
Michael Jay Ross Director 15 Jun 2022
Edward C. English Principal Accounting Officer 01 Jan 2023
Paul J. Clancy Director 11 Jun 2025

Recent Insider Transactions by Companies or Individuals for Xilio Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.